Nanosonics Limited (NAN.AX) Stock Analysis & Winston Score

Nanosonics is an Australian medical device company that makes equipment used to clean and disinfect ultrasound probes — the handheld devices doctors use to look inside the body. Its main product is the trophon, a machine that automatically disinfects ultrasound probes between patients to prevent the spread of infection. Hospitals and medical clinics around the world are its primary customers. The company makes money in two ways: selling the trophon machines upfront and then charging ongoing fees for the single-use consumable cartridges each disinfection cycle requires. This "razor and blades" model means recurring revenue grows as more machines are installed. Nanosonics operates mainly in the United States, Australia, and parts of Europe, and its installed base of machines creates a sticky revenue stream that is hard for competitors to displace quickly. The key growth driver is expanding its installed base globally and launching new products beyond ultrasound probe disinfection, while the main risk is its heavy dependence on a single product line.